Trial Search Results

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University




Inclusion Criteria:

   - 18 years of age or older

   - Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic
   disorder being examined.

   - Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

- Less than 18 years of age

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305